Design of gp120 HIV-1 entry inhibitors by scaffold hopping via isosteric replacements-Reference-Cited by-同舟云学术

Design of gp120 HIV-1 entry inhibitors by scaffold hopping via isosteric replacements

Published:2021-11 Issue: Volume:224 Page:113681
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Iusupov Ildar R.,Curreli Francesca,Spiridonov Evgeniy A.,Markov Pavel O.,Ahmed Shahad,Belov Dmitry S.,Manasova Ekaterina V.,Altieri Andrea^ORCID,Kurkin Alexander V.,Debnath Asim K.

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference35 articles.

1. HIV: cell binding and entry;Wilen;Cold Spring Harbor Perspect. Med.,2012

2. Guanidine-containing phenyl-pyrrole compounds as probes for generating HIV nntry inhibitors targeted to gp120;Belov;ChemistrySelect,2018

3. Fusion and binding inhibition" key target for HIV-1 treatment and pre-exposure prophylaxis: targets, drug delivery and nanotechnology approaches;Malik;Drug Deliv.,2017

4. Hybrids of small-molecule CD4 mimics with polyethylene glycol units as HIV entry inhibitors;Kobayakawa;J. Med. Chem.,2021

5. Rational design of A novel small-molecule HIV-1 inactivator targeting both gp120 and gp41 of HIV-1;Pu;Front. Pharmacol.,2020

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revealing the Indispensable Role of the RFamide Functionality using a Novel Acid Labile Benzofuranone based Amine (ALBA) Linker;Helvetica Chimica Acta;2024-03-12

2. Implications of Fragment-Based Drug Discovery in Tuberculosis and HIV;Pharmaceuticals;2022-11-15

3. Design, Synthesis, and Antiviral Activity of the Thiazole Positional Isomers of a Potent HIV‐1 Entry Inhibitor NBD‐14270;ChemMedChem;2022-09-29

4. Recent research results have converted gp120 binders to a therapeutic option for the treatment of HIV-1 infection. A medicinal chemistry point of view;European Journal of Medicinal Chemistry;2022-02

5. Discovery of Novel Polycyclic Heterocyclic Derivatives from Evodiamine for the Potential Treatment of Triple-Negative Breast Cancer;Journal of Medicinal Chemistry;2021-11-30